Oasmia Pharma (OASM) Says It's in Discussions on Acquisition of Novel Cancer Project

October 21, 2016 4:22 PM EDT
Get Alerts OASM Hot Sheet
Trade OASM Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

The pharmaceutical company Oasmia Pharmaceutical AB (NASDAQ: OASM) announce today that the company is in discussions concerning acquisition of a novel cancer project.

More information will be released on Monday at the latest.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Corporate News, Mergers and Acquisitions

Related Entities

Definitive Agreement

Comments

M&A guru Anders Lönner
Andy on 2016-10-23 08:46:37
Mark as Spam | Reply to this comment

There is also plenty of speculation regarding Swedish M&A guru Anders Lönner becoming a major shareholder. Also behind the Mylan-Meda deal.


Add Your Comment